Hero Image

A Guide to Wegovy Patient Assistance Programs

If you’ve been prescribed Wegovy but worry about the cost, patient assistance programs can help make treatment more affordable.

In this guide, we’ll cover what Wegovy is, how assistance programs work, who’s eligible, how to apply, what to expect for timelines and costs, and where to find reliable, free support.

What Is Wegovy?

Wegovy (semaglutide) is a once-weekly prescription GLP-1 medicine used for chronic weight management in adults with obesity (BMI ≥30) or overweight (BMI ≥27) with at least one weight-related condition (like type 2 diabetes, high blood pressure, or high cholesterol). In 2024, Wegovy also gained an indication to reduce the risk of major cardiovascular events in certain adults with established heart disease and overweight or obesity—an update that may improve insurance coverage for some patients.

In clinical studies, many patients lost an average of around 15% of their body weight over time when Wegovy was combined with nutrition, physical activity, and behavior changes. Trials in people with cardiovascular disease also showed meaningful risk reduction, which is part of why some insurers now review Wegovy differently for members with heart disease.

Common side effects include nausea, vomiting, diarrhea, and constipation—often improving as dosing is slowly increased. Wegovy carries a boxed warning about thyroid C-cell tumors and should not be used by anyone with a personal or family history of medullary thyroid carcinoma (MTC) or multiple endocrine neoplasia syndrome type 2 (MEN 2). Talk with your clinician to decide if Wegovy is appropriate for you and to discuss risks and benefits.

How Patient Assistance Programs Work

“Patient assistance” for Wegovy generally falls into three buckets. Understanding which one applies to you helps you save time and maximize your chances of getting help:

  • Manufacturer savings cards (copay programs): For people with commercial or employer-sponsored insurance that covers Wegovy. These offers can significantly lower your copay, subject to program limits and terms. They’re not valid for patients on Medicare, Medicaid, TRICARE, or other government insurance. See the official savings and support page at wegovy.com/savings-and-support.
  • Manufacturer Patient Assistance Programs (PAPs): Typically provide medicine at no cost for eligible patients who are uninsured or underinsured and meet income and other criteria. For Wegovy, explore NovoCare (Novo Nordisk’s support hub) to review current PAP eligibility and applications.
  • Pharmacy discount programs and coupons: Third-party tools (e.g., price comparison sites) may reduce cash prices at participating pharmacies, but they’re separate from manufacturer programs and usually can’t be combined with insurance. For price comparisons, see GoodRx.

Who Is Eligible for Wegovy Assistance?

Each program sets its own rules, but these general guidelines can help you gauge your options:

  • Insurance status:
    • Commercially insured and your plan covers Wegovy? You may qualify for a manufacturer savings card to lower copays.
    • Commercially insured but your plan denies coverage? You may need a prior authorization (PA) or an exception/appeal. Savings cards usually require the drug be covered by your plan.
    • Uninsured or you’ve lost coverage? Look into the manufacturer PAP via NovoCare.
    • Medicare/Medicaid/other government insurance? Copay cards usually aren’t allowed. Some PAPs exclude government-insured patients; however, coverage for Wegovy under certain cardiovascular indications may be available through specific Part D plans—check your plan’s formulary.
  • Income limits: PAPs often require household income at or below a set percentage of the Federal Poverty Level (FPL), commonly around 300–400% FPL. Check current thresholds using the official HHS Poverty Guidelines.
  • Residency: Many PAPs require U.S. citizenship or legal residency and a U.S. shipping address.
  • Prescription and diagnosis: You’ll need a valid prescription and a diagnosis that aligns with Wegovy’s FDA-approved uses.
  • Medical necessity documentation: For PAs or appeals, plans may ask for BMI, weight history, comorbidities, and prior treatments tried.

How to Apply: A Step-by-Step Playbook

1) Confirm coverage and identify the right path

  • Call the number on your insurance card or check your plan’s portal for Wegovy’s formulary status, preferred pharmacies, and PA requirements. If you have established cardiovascular disease, ask specifically about coverage under the CV risk-reduction indication.
  • If uninsured (or if coverage is denied and you meet income criteria), go to NovoCare to review the Wegovy Patient Assistance Program.

2) Gather your documents

  • Proof of income (recent pay stubs, tax return, benefits letter)
  • Proof of U.S. residence and identity (as required)
  • Insurance details (front/back of card), if applicable
  • Prescription information and your prescriber’s contact details

3) Complete and submit the application

  • Many PAPs offer online applications; others allow you to download forms to sign and upload, fax, or mail.
  • Most forms require a section completed and signed by your prescriber. Coordinate with the clinic so nothing is missing.
  • If you’re using a savings card, activate it online and make sure the pharmacy processes it with your primary insurance as required.

4) Work with your clinic on prior authorization or appeals

  • For PAs, your clinician typically submits: BMI, relevant diagnoses, prior treatments tried/failed, and a rationale for Wegovy (e.g., CV risk reduction if applicable).
  • If denied, ask your provider to file an appeal or a letter of medical necessity addressing the plan’s reasons for denial and citing your comorbidities and treatment goals.
  • Track deadlines—appeal windows can be short (e.g., 30–60 days).

5) Know the timelines and follow up

  • Savings cards: Often usable immediately if your plan covers Wegovy.
  • PAP decisions: Commonly 1–2 weeks after a complete application; shipments may go to your prescriber’s office or a specialty pharmacy.
  • Call to confirm the pharmacy has stock and can handle cold-chain shipping or pickup.

6) Refill and re-enroll

  • PAP approvals may last 6–12 months. Mark your calendar for re-enrollment to avoid gaps.
  • Keep copies of documents so re-enrollment is faster next time.

Costs, Timelines, and What to Expect

  • List price: Wegovy’s U.S. cash price is typically over $1,300/month. Savings cards and PAPs exist to offset this.
  • Out-of-pocket with insurance: Copays vary widely by plan and deductible. Manufacturer savings may reduce copays substantially if you qualify.
  • PAP cost: $0 for the medication if approved; you may still have costs for clinic visits or supplies.
  • Supply and availability: Some strengths may be backordered. Ask your prescriber to send the script to a pharmacy with supply, or request to be added to a waitlist. Starting doses are titrated gradually (0.25 mg → 0.5 mg → higher), which may help with availability.
  • Cold-chain handling: Wegovy must be refrigerated. Confirm shipping timelines and pickup windows to keep pens within the recommended temperature range.

Additional Resources and Free Support

Smart Tips to Improve Your Chances

  • Document everything: Track weights, BMI, comorbidities, and prior treatments tried/failed—these strengthen PAs and appeals.
  • Ask about coverage under the CV indication: If you have established cardiovascular disease, your plan may evaluate Wegovy differently.
  • Use preferred pharmacies: Some plans require specialty or mail-order pharmacies for GLP-1 medications.
  • Coordinate refills early: Call 1–2 weeks before you’ll run out, especially if supply is tight.
  • Know your HR benefits: Employer plans sometimes allow formulary exceptions or case management for complex conditions.

Frequently Asked Questions

  • Can I use a savings card if I’m on Medicare or Medicaid? No. Federal rules generally prohibit using manufacturer copay cards with government insurance. Check your plan’s formulary for coverage options, especially under cardiovascular indications.
  • Can I get Wegovy for free? Possibly, through a manufacturer PAP if you meet income and other eligibility requirements. Start at NovoCare.
  • What if the pharmacy is out of stock? Ask about backorders, alternative pharmacies, or being placed on a waitlist. Your prescriber may need to adjust the prescription to available strengths.
  • Is compounded semaglutide a safe alternative? Compounded versions are not FDA-approved, and the FDA has issued safety cautions. See the FDA’s overview on compounding here; discuss risks with your clinician.
  • How long does approval take? Savings cards can be immediate if coverage exists. PAP and PA decisions often take 1–2 weeks once all documents are received.

Bottom line: Wegovy patient assistance programs can substantially reduce costs—sometimes to $0—if you match the right program to your insurance status and income. Use the steps and resources above to speed up approvals, avoid common pitfalls, and stay on track with your treatment plan.